EMERALD BIOSCIENCE RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHThu, 28 May 2026 16:07:41 +0200https://images.finanzen.net/images/finanzen_net_neu.gifEMERALD BIOSCIENCE RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netHalozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated with ENHANZE® for ObesityMon, 05 Jan 2026 13:00:00 +0100https://www.finanzen.net/nachricht/aktien/halozyme-and-skye-bioscience-announce-global-collaboration-and-license-agreement-to-evaluate-nimacimab-co-formulated-with-enhanze-for-obesity-15391982

Agreement supports development and commercialization of higher-dose, subcutaneous administration strategies for nimacimab

]]>https://www.finanzen.net/nachricht/aktien/halozyme-and-skye-bioscience-announce-global-collaboration-and-license-agreement-to-evaluate-nimacimab-co-formulated-with-enhanze-for-obesity-15391982Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYEMon, 29 Dec 2025 07:25:00 +0100https://www.finanzen.net/nachricht/aktien/skye-bioscience-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-skye-15382101

LOS ANGELES, Dec. 29, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/skye-bioscience-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-skye-15382101SHAREHOLDER ACTION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye BioscienceTue, 23 Dec 2025 17:06:00 +0100https://www.finanzen.net/nachricht/aktien/shareholder-action-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-skye-bioscience-15377385

Faruqi & Faruqi, LLP Securities Litigation Partner ]]>https://www.finanzen.net/nachricht/aktien/shareholder-action-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-skye-bioscience-15377385ATTENTION NASDAQ: SKYE INVESTORS: Contact Berger Montague About a Skye Bioscience, Inc. Class Action LawsuitThu, 18 Dec 2025 15:06:00 +0100https://www.finanzen.net/nachricht/aktien/attention-nasdaq-skye-investors-contact-berger-montague-about-a-skye-bioscience-inc-class-action-lawsuit-15368371

PHILADELPHIA, Dec. 18, 2025 /PRNewswire/ -- National plaintiffs' law firm https://www.finanzen.net/nachricht/aktien/attention-nasdaq-skye-investors-contact-berger-montague-about-a-skye-bioscience-inc-class-action-lawsuit-15368371Levi & Korsinsky Notifies Skye Bioscience, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SKYEFri, 12 Dec 2025 15:00:00 +0100https://www.finanzen.net/nachricht/aktien/levi-korsinsky-notifies-skye-bioscience-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-skye-15355391

NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Skye Bioscience, ...

]]>https://www.finanzen.net/nachricht/aktien/levi-korsinsky-notifies-skye-bioscience-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-skye-15355391Berger Montague PC Investigating Claims on Behalf of Skye Bioscience, Inc. (NASDAQ: SKYE) Investors After Class Action FilingTue, 09 Dec 2025 18:40:00 +0100https://www.finanzen.net/nachricht/aktien/berger-montague-pc-investigating-claims-on-behalf-of-skye-bioscience-inc-nasdaq-skye-investors-after-class-action-filing-15346942

PHILADELPHIA, Dec. 9, 2025 /PRNewswire/ -- National plaintiffs' law firm https://www.finanzen.net/nachricht/aktien/berger-montague-pc-investigating-claims-on-behalf-of-skye-bioscience-inc-nasdaq-skye-investors-after-class-action-filing-15346942Lawsuit DEADLINE: Investors who purchased over $100,000 worth of shares of Skye Bioscience, Inc. (NASDAQ: SKYE) between Nov. 2024 and Oct. 2025 should contact the Shareholders FoundationMon, 08 Dec 2025 13:11:00 +0100https://www.finanzen.net/nachricht/aktien/lawsuit-deadline-investors-who-purchased-over-100-000-worth-of-shares-of-skye-bioscience-inc-nasdaq-skye-between-nov-2024-and-oct-2025-should-contact-the-shareholders-foundation-15342355

SAN DIEGO, Dec. 8, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that a deadline is ...

]]>https://www.finanzen.net/nachricht/aktien/lawsuit-deadline-investors-who-purchased-over-100-000-worth-of-shares-of-skye-bioscience-inc-nasdaq-skye-between-nov-2024-and-oct-2025-should-contact-the-shareholders-foundation-15342355Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYEMon, 08 Dec 2025 08:55:00 +0100https://www.finanzen.net/nachricht/aktien/skye-bioscience-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-skye-15341656

LOS ANGELES, Dec. 8, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/skye-bioscience-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-skye-15341656Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYEThu, 04 Dec 2025 13:42:00 +0100https://www.finanzen.net/nachricht/aktien/skye-bioscience-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-skye-15335193

LOS ANGELES, Dec. 4, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/skye-bioscience-inc-sued-for-securities-law-violations-contact-the-djs-law-group-to-discuss-your-rights-skye-15335193SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law FirmThu, 04 Dec 2025 13:41:00 +0100https://www.finanzen.net/nachricht/aktien/skye-investors-have-opportunity-to-lead-skye-bioscience-inc-securities-fraud-lawsuit-with-the-schall-law-firm-15335194

LOS ANGELES, Dec. 4, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/skye-investors-have-opportunity-to-lead-skye-bioscience-inc-securities-fraud-lawsuit-with-the-schall-law-firm-15335194